Enrolling Clinical Studies

shutterstock_1902795295_edited.jpg

NON-ALCOHOLIC FATTY LIVER DISEASE (NASH)

This study will evaluate the long term efficacy and safety of a medication in patients with non alcoholic and non cirrhotic fatty liver disease.

Requirements:

• Men & Women 18 years of age or older
• Positive history of fatty liver
• Not suffering of cirrhosis related of alcohol abuse
• No history of other liver condition (like hepatitis)
• No history of heart condition or other major health condition

Study Duration:

This duration of this study is 7 years.

Compensation:

Eligible participants will receive financial compensation of $104 per study-related office visit and $1,500 for biopsies (3 biopsies required).